Prevalence and complication of COVID‐19 in patients with ankylosing spondylitis (AS) and its relationship with TNF‐a inhibitors

Prevalence and complication of COVID‐19 in patients with ankylosing spondylitis (AS) and its relationship with TNF‐a inhibitors

Abstract Introduction Ankylosing spondylitis (AS) is a condition that is treated with nonsteroidal anti‐inflammatory drugs and biological drugs such as anti tumor necrosis factor alpha (TNF‐α). This study examined the prevalence of COVID‐19 among individuals with AS and compare it between those rece...

Full description

Saved in:
Bibliographic Details
Main Authors: Shafieh Movassaghi, SeyedAhmad SeyedAlinaghi, Abdolrahman Rostamian, Seyed Reza Najafizadeh, Elham Nezhadseifi
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Immunity, Inflammation and Disease
Subjects:
ankylosing spondylitis
biological drugs
COVID‐19
outcomes
Online Access:https://doi.org/10.1002/iid3.915
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items